請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/83031完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 林中天 | zh_TW |
| dc.contributor.advisor | Chung-Tien Lin | en |
| dc.contributor.author | 吳羿穎 | zh_TW |
| dc.contributor.author | Yi-Ying Wu | en |
| dc.date.accessioned | 2022-11-25T08:05:38Z | - |
| dc.date.available | 2026-10-01 | - |
| dc.date.copyright | 2021-11-05 | - |
| dc.date.issued | 2021 | - |
| dc.date.submitted | 2002-01-01 | - |
| dc.identifier.citation | Absolon, M. J., & Brown, C. A. (1968). Acetylcysteine in kerato-conjunctivitis sicca. Br J Ophthalmol, 52(4), 310-316. https://doi.org/10.1136/bjo.52.4.310
Aldavood, S. J., Behyar, R., Sarchahi, A. A., Rad, M. A., Noroozian, I., Ghamsari, S. M., & Sadeghi-Hashjin, G. (2003). Effect of acetylcysteine on experimental corneal wounds in dogs. Ophthalmic Res, 35(6), 319-323. https://doi.org/10.1159/000074070 Arima, T., Uchiyama, M., Shimizu, A., & Takahashi, H. (2020). Observation of Corneal Wound Healing and Angiogenesis Using Low-Vacuum Scanning Electron Microscopy. Transl Vis Sci Technol, 9(6), 14. https://doi.org/10.1167/tvst.9.6.14 Bastawrous, A., Silvester, A., & Batterbury, M. (2011). Laser refractive eye surgery. Bmj, 342, d2345. https://doi.org/10.1136/bmj.d2345 Bian, F., Pelegrino, F. S., Pflugfelder, S. C., Volpe, E. A., Li, D. Q., & de Paiva, C. S. (2015). Desiccating Stress-Induced MMP Production and Activity Worsens Wound Healing in Alkali-Burned Corneas. Invest Ophthalmol Vis Sci, 56(8), 4908-4918. https://doi.org/10.1167/iovs.15-16631 Burstein, N. L. (1980). Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest Ophthalmol Vis Sci, 19(3), 308-313. Byun, Y. S., Yoo, Y. S., Kwon, J. Y., Joo, J. S., Lim, S. A., Whang, W. J., Mok, J. W., Choi, J. S., & Joo, C. K. (2016). Diquafosol promotes corneal epithelial healing via intracellular calcium-mediated ERK activation. Exp Eye Res, 143, 89-97. https://doi.org/10.1016/j.exer.2015.10.013 Cavaliere, R. M., Ghirardi, F., & Tirindelli, R. (2014). Lacrimal gland removal impairs sexual behavior in mice. Frontiers in neuroanatomy, 8, 101-101. https://doi.org/10.3389/fnana.2014.00101 Choi, H., Phillips, C., Oh, J. Y., Stock, E. M., Kim, D. K., Won, J. K., & Fulcher, S. (2017). Comprehensive Modeling of Corneal Alkali Injury in the Rat Eye. Curr Eye Res, 42(10), 1348-1357. https://doi.org/10.1080/02713683.2017.1317817 Choi, K. E., Song, J. S., Kang, B., Eom, Y., & Kim, H. M. (2017). Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models. Curr Eye Res, 42(5), 666-671. https://doi.org/10.1080/02713683.2016.1233986 Eghtedari, Y., Oh, L. J., Girolamo, N. D., & Watson, S. L. (2021). The role of topical N-acetylcysteine in ocular therapeutics. Survey of Ophthalmology. https://doi.org/https://doi.org/10.1016/j.survophthal.2021.07.008 Fini, M. E., Girard, M. T., & Matsubara, M. (1992). Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol Suppl(202), 26-33. https://doi.org/10.1111/j.1755-3768.1992.tb02165.x Fujihara, T., Murakami, T., Fujita, H., Nakamura, M., & Nakata, K. (2001). Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci, 42(1), 96-100. Gordon, G. M., Ledee, D. R., Feuer, W. J., & Fini, M. E. (2009). Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells. J Cell Physiol, 221(2), 402-411. https://doi.org/10.1002/jcp.21869 Green, K., Johnson, R. E., Chapman, J. M., Nelson, E., & Cheeks, L. (1989). Surfactant Effects on the Rate of Rabbit Corneal Epithelial Healing. Journal of Toxicology: Cutaneous and Ocular Toxicology, 8(3), 253-269. https://doi.org/10.3109/15569528909062930 Gujral, G. S., Askari, S. N., Ahmad, S., Zakir, S. M., & Saluja, K. (2020). Topical vitamin C, vitamin E, and acetylcysteine as corneal wound healing agents: A comparative study. Indian J Ophthalmol, 68(12), 2935-2939. https://doi.org/10.4103/ijo.IJO_1463_20 Holzchuh, R., Villa Albers, M. B., Osaki, T. H., Igami, T. Z., Santo, R. M., Kara-Jose, N., Holzchuh, N., & Hida, R. Y. (2011). Two-year outcome of partial lacrimal punctal occlusion in the management of dry eye related to Sjögren syndrome. Curr Eye Res, 36(6), 507-512. https://doi.org/10.3109/02713683.2011.569870 Hori, Y., Kageyama, T., Sakamoto, A., Shiba, T., Nakamura, M., & Maeno, T. (2017). Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface. J Ocul Pharmacol Ther, 33(6), 493-497. https://doi.org/10.1089/jop.2016.0092 Hwang, H. S., Sung, Y. M., Lee, W. S., & Kim, E. C. (2014). Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops. Cornea, 33(9), 935-941. https://doi.org/10.1097/ico.0000000000000213 Jamerson, E. C., Elhusseiny, A. M., ElSheikh, R. H., Eleiwa, T. K., & El Sayed, Y. M. (2020). Role of Matrix Metalloproteinase 9 in Ocular Surface Disorders. Eye & Contact Lens, 46, S57-S63. https://doi.org/10.1097/icl.0000000000000668 Kim, T. I., Alió Del Barrio, J. L., Wilkins, M., Cochener, B., & Ang, M. (2019). Refractive surgery. Lancet, 393(10185), 2085-2098. https://doi.org/10.1016/s0140-6736(18)33209-4 Koh, S., Ikeda, C., Takai, Y., Watanabe, H., Maeda, N., & Nishida, K. (2013). Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye. Jpn J Ophthalmol, 57(5), 440-446. https://doi.org/10.1007/s10384-013-0251-y Lee, J. H., Lee, J. S., Kim, S., & Lee, J. E. (2017). Comparison of cytotoxicities and wound healing effects of diquafosol tetrasodium and hyaluronic acid on human corneal epithelial cells. Korean J Physiol Pharmacol, 21(2), 189-195. https://doi.org/10.4196/kjpp.2017.21.2.189 Li, X., Kang, B., Woo, I. H., Eom, Y., Lee, H. K., Kim, H. M., & Song, J. S. (2018). Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye. Invest Ophthalmol Vis Sci, 59(7), 3104-3114. https://doi.org/10.1167/iovs.18-23860 Lima, T. B., Ribeiro, A. P., Conceição, L. F., Bandarra, M., Manrique, W. G., & Laus, J. L. (2015). Ketorolac eye drops reduce inflammation and delay re-epithelization in response to corneal alkali burn in rabbits, without affecting iNOS or MMP-9. Arq Bras Oftalmol, 78(2), 67-72. https://doi.org/10.5935/0004-2749.20150019 Maycock, N. J., & Marshall, J. (2014). Genomics of corneal wound healing: a review of the literature. Acta Ophthalmol, 92(3), e170-184. https://doi.org/10.1111/aos.12227 Mohan, R., Chintala, S. K., Jung, J. C., Villar, W. V., McCabe, F., Russo, L. A., Lee, Y., McCarthy, B. E., Wollenberg, K. R., Jester, J. V., Wang, M., Welgus, H. G., Shipley, J. M., Senior, R. M., & Fini, M. E. (2002). Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem, 277(3), 2065-2072. https://doi.org/10.1074/jbc.M107611200 Moon, I., Kang, H. G., Yeo, A., Noh, H., Kim, H. C., Song, J. S., Ji, Y. W., & Lee, H. K. (2018). Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model. J Ocul Pharmacol Ther, 34(9), 612-620. https://doi.org/10.1089/jop.2018.0005 Ormerod, L. D., Abelson, M. B., & Kenyon, K. R. (1989). Standard models of corneal injury using alkali-immersed filter discs. Investigative Ophthalmology & Visual Science, 30(10), 2148-2153. Pan, Q., Qiu, W. Y., Huo, Y. N., Yao, Y. F., & Lou, M. F. (2011). Low levels of hydrogen peroxide stimulate corneal epithelial cell adhesion, migration, and wound healing. Invest Ophthalmol Vis Sci, 52(3), 1723-1734. https://doi.org/10.1167/iovs.10-5866 Park, C. H., Lee, H. K., Kim, M. K., Kim, E. C., Kim, J. Y., Kim, T.-i., Kim, H. K., Song, J. S., Yoon, K. C., Lee, D. H., Chung, T.-Y., Choi, C. Y., & Kim, H. S. (2019). RETRACTED ARTICLE: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial. BMC Ophthalmology, 19(1), 131. https://doi.org/10.1186/s12886-019-1136-8 Park, J. H., Moon, S. H., Kang, D. H., Um, H. J., Kang, S. S., Kim, J. Y., & Tchah, H. (2018). Diquafosol Sodium Inhibits Apoptosis and Inflammation of Corneal Epithelial Cells Via Activation of Erk1/2 and RSK: In Vitro and In Vivo Dry Eye Model. Invest Ophthalmol Vis Sci, 59(12), 5108-5115. https://doi.org/10.1167/iovs.17-22925 Petroutsos, G., Guimaraes, R., Giraud, J. P., Renard, G., & Pouliquen, Y. (1982). Effect of acetylcysteine (Mucomyst) on epithelial wound healing. Ophthalmic Res, 14(4), 241-248. https://doi.org/10.1159/000265198 Petznick, A., Madigan, M. C., Garrett, Q., Sweeney, D. F., & Evans, M. D. (2013). Contributions of ocular surface components to matrix-metalloproteinases (MMP)-2 and MMP-9 in feline tears following corneal epithelial wounding. PLoS One, 8(8), e71948. https://doi.org/10.1371/journal.pone.0071948 Pflugfelder, S. C., Farley, W., Luo, L., Chen, L. Z., de Paiva, C. S., Olmos, L. C., Li, D. Q., & Fini, M. E. (2005). Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol, 166(1), 61-71. https://doi.org/10.1016/s0002-9440(10)62232-8 Ramaesh, T., Ramaesh, K., Riley, S. C., West, J. D., & Dhillon, B. (2012). Effects of N-acetylcysteine on matrix metalloproteinase-9 secretion and cell migration of human corneal epithelial cells. Eye (Lond), 26(8), 1138-1144. https://doi.org/10.1038/eye.2012.135 Rouen, P. A., & White, M. L. (2018). Dry Eye Disease: Prevalence, Assessment, and Management. Home Healthc Now, 36(2), 74-83. https://doi.org/10.1097/nhh.0000000000000652 Saravanan, C., Cao, Z., Head, S. R., & Panjwani, N. (2010). Analysis of differential expression of glycosyltransferases in healing corneas by glycogene microarrays. Glycobiology, 20(1), 13-23. https://doi.org/10.1093/glycob/cwp133 Schrader, S., Mircheff, A. K., & Geerling, G. (2008). Animal models of dry eye. Dev Ophthalmol, 41, 298-312. https://doi.org/10.1159/000131097 Shinomiya, K., Ueta, M., & Kinoshita, S. (2018). A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision. Sci Rep, 8(1), 1483. https://doi.org/10.1038/s41598-018-19578-6 Shirai, K., Okada, Y., Cheon, D. J., Miyajima, M., Behringer, R. R., Yamanaka, O., & Saika, S. (2014). Effects of the loss of conjunctival Muc16 on corneal epithelium and stroma in mice. Invest Ophthalmol Vis Sci, 55(6), 3626-3637. https://doi.org/10.1167/iovs.13-12955 Singh, A., Maurya, O. P., Jagannadhan, M. V., & Patel, A. (2012). Matrix metalloproteinases (MMP-2 and MMP-9) activity in corneal ulcer and ocular surface disorders determined by gelatin zymography. J Ocul Biol Dis Infor, 5(2), 31-35. https://doi.org/10.1007/s12177-012-9096-8 Skrzypecki, J., Tomasz, H., & Karolina, C. (2019). Variability of Dry Eye Disease Following Removal of Lacrimal Glands in Rats. Adv Exp Med Biol, 1153, 109-115. https://doi.org/10.1007/5584_2019_348 Stevenson, W., Chen, Y., Lee, S. M., Lee, H. S., Hua, J., Dohlman, T., Shiang, T., & Dana, R. (2014). Extraorbital lacrimal gland excision: a reproducible model of severe aqueous tear-deficient dry eye disease. Cornea, 33(12), 1336-1341. https://doi.org/10.1097/ico.0000000000000264 Subasi, S., Altintas, O., Yardimoglu, M., Yazir, Y., Karaman, S., Rencber, S. F., & Kavram, K. (2017). Comparison of Collagen Cross-Linking and Amniotic Membrane Transplantation in an Experimental Alkali Burn Rabbit Model. Cornea, 36(9), 1106-1115. https://doi.org/10.1097/ico.0000000000001276 Torricelli, A. A., Bechara, S. J., & Wilson, S. E. (2014). Screening of refractive surgery candidates for LASIK and PRK. Cornea, 33(10), 1051-1055. https://doi.org/10.1097/ico.0000000000000171 Tragoulias, S. T., & Anderton, P. J. (2001). The effect of N-acetylcysteine on the microscopic fluid dynamics of rat tears. Clin Exp Optom, 84(5), 282-286. https://doi.org/10.1111/j.1444-0938.2001.tb05039.x Wilson, S. E. (2020). Corneal wound healing. Exp Eye Res, 197, 108089. https://doi.org/10.1016/j.exer.2020.108089 Yang, L., Zhang, S., Duan, H., Dong, M., Hu, X., Zhang, Z., Wang, Y., Zhang, X., Shi, W., & Zhou, Q. (2019). Different Effects of Pro-Inflammatory Factors and Hyperosmotic Stress on Corneal Epithelial Stem/Progenitor Cells and Wound Healing in Mice. Stem Cells Transl Med, 8(1), 46-57. https://doi.org/10.1002/sctm.18-0005 Yin, J., Huang, J., Chen, C., Gao, N., Wang, F., & Yu, F. S. (2011). Corneal complications in streptozocin-induced type I diabetic rats. Invest Ophthalmol Vis Sci, 52(9), 6589-6596. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/83031 | - |
| dc.description.abstract | 背景:屈光不正是常見造成視力受損的原因之一,其中最常見的情況為近視。雷射屈光角膜切削術(Photorefractive keratectomy,縮寫PRK)為其中一種角膜屈光手術方式,此方法最大的不同點是手術過程中需要移除角膜上皮。同時,乾眼症也是常見的眼科疾病之一,已知配戴隱形眼鏡為患有乾眼症的風險因子之一,因此可以得知可能有部分的近視病患同時患有乾眼症。若是患有乾眼症的病患需要進行雷射屈光角膜切削術時,可能會承受比其他病患更多的副作用。若有點眼藥物能夠促進乾眼症病患的角膜上皮傷口癒合速度,也許能夠減輕這些病患的不適程度、達到更好的預後。近年來,一種黏蛋白促泌劑,滴舒適®點眼液(3% diquafosol sodium)逐漸被用來當作新興的乾眼症治療方法,而乙醯半胱氨酸(0.66%, 3%, 10% N-acetylcysteine)則是一種可以溶解黏液的藥物,臨床上曾用來治療乾眼症病患的黏液斑(mucous plaque)卻也有研究用其來誘導黏蛋白不足型的乾眼症模型。因此,為了瞭解這兩種藥物對於乾眼症病患的效果以及對於乾眼症病患的角膜傷口癒合的影響,本研究將這兩種藥物使用在同時具有乾眼症以及角膜上皮傷口的大鼠模型上進行分析。
目的:在乾眼症的大鼠模型上製造角膜上皮傷口,以模擬這些病患的狀況,接著觀察滴舒適®點眼液(3% diquafosol sodium)和三種不同濃度的乙醯半胱氨酸(0.66%, 3%, 10% N-acetylcysteine)在正常情況下以及乾眼症情況下,對角膜上皮傷口癒合和對角膜基質金屬蛋白酵素9(Matrix metalloproteinase-9,縮寫MMP-9)的影響。 方法:將18隻Sprague-Dawley大鼠隨機分成6組:控制組、DQS組、0.66% NAC組、3% NAC組、10% NAC組和乾眼症控制(沒有誘導角膜傷口且沒有給予任何眼藥水治療)組,而每隻大鼠的右眼為治療眼、左眼則為控制眼。第0天時,所有大鼠右眼的眶外淚腺(extraorbital lacrimal gland)和眼後淚腺(infraorbital lacrimal gland)皆會手術切除。第2天時,五個治療組的大鼠雙眼皆會進行角膜上皮傷口誘導手術,並在術後開始給予一天四次的眼藥水,包含了預防性的抗生素眼藥水以及各組指定的眼藥水。乾眼症控制組的大鼠不會接受此手術以及任何眼藥水。角膜上皮傷口製造後的第0, 8, 24, 32, 48, 72小時,會進行傷口大小的評估及拍照紀錄。第72小時後,所有大鼠皆會進行犧牲,並將角膜完整取下進行即時聚合酶連鎖反應(Real-time polymerase chain reaction)分析其基質金屬蛋白酵素9的表現量。大鼠的淚水量、傷口癒合速度及角膜基質金屬蛋白酵素9的表現量等皆會進行統計分析。 結果:切除淚腺後的右眼其淚水量在術後一天淚水量顯著下降直到實驗結束,左眼的淚水量皆維持與第0天相似的值,其中左眼可看到淚水量在第3天時有上升的情形,可能與角膜傷口造成的疼痛刺激有關。在每一組別中的大鼠,切除淚腺後的右眼其角膜螢光染色的評分在進行角膜上皮傷口誘導前,皆顯示顯著上升,代表所有大鼠的右眼角膜表面皆出現了顯著的乾眼症變化。在五組治療組中,每一組角膜上皮傷口癒合的速度右眼皆顯著較左眼慢。而在各組的右眼傷口,術後48小時為止各組間傷口的傷口大小皆無顯著差異,而在術後72小時,0.66% NAC和10% NAC兩組的角膜傷口皆顯著較控制組大。而各組的左眼傷口,在術後第24小時,0.66% NAC和10% NAC兩組的傷口面積皆顯著較DQS和控制組大,而術後第32小時,0.66% NAC、3% NAC和10% NAC三組的傷口面積皆顯著較控制組大。而各組角膜的基質金屬蛋白酵素9表現量,右眼皆顯著比左眼高。各組的左眼之間沒有顯著的差異; 各組的右眼間控制組顯著較其他四組治療組高,其中DQS和3% NAC兩組的表現量也顯著較10% NAC組高。控制組和乾眼症控制組相比,控制組右眼的基質金屬蛋白酵素9表現量也顯著較乾眼症組的右眼高。 結論:滴舒適®點眼液和三種不同濃度的乙醯半胱氨酸在正常眼和患有乾眼症的眼睛上,都無法顯著促進角膜上皮傷口的癒合,其中0.66% NAC和10% NAC可能會延緩傷口的癒合。在乾眼症病患的治療上,滴舒適®點眼液和乙醯半胱氨酸皆是可能會使用的藥物,但這些藥物在病患有角膜上皮傷口時使用,可能會延緩角膜上皮傷口的癒合速度。在乾眼症病患上,抑制角膜基質金屬蛋白酵素9的表現量並不是能夠促進角膜上皮傷口癒合的治療方向。 | zh_TW |
| dc.description.abstract | Background: Refractive error is one of the most common causes of reversible visual impairment. Among these refractive error conditions, myopia is the most common problem. Photorefractive keratectomy (PRK) is one of the corrective refractive surgeries. The most specific procedure of PRK is the removal of corneal epithelium. Besides, dry eye disease is also one of the general ocular diseases. And, contact lens use is one of the risk factors of dry eye disease. It means that there are part of myopia patients may also suffer from dry eye disease. However, the patient who would like to receive PRK surgery with pre-existing dry eye disease may suffer more pain than others. Drugs that can improve corneal epithelial wound healing in dry eye patient may substantially diminish the side effects. Recently, the mucin secretagogues, diquafosol eye drops, is used as a novel therapeutic option of dry eye disease. On the contrary, N-acetylcysteine is a mucolytic agent. In prior literatures, the drugs had been used to treat mucous plaques in dry eye patients. However, it also been used to induce mucin-deficiency dry eye animal model. In order to investigate the effect of these two drugs on dry eye patient and on wound healing, we applied these two drugs to animal models which suffered both dry eye disease and corneal epithelial wound.
Purposes: We tried to build up a dry eye rat model and mimicked the PRK surgery to induce the corneal epithelial wound. Then, the effect of diquafosol and three different concentrations of N-acetylcysteine on corneal epithelial wound healing and MMP-9 expression level were evaluated. Methods: Eighteen Sprague-Dawley were randomly divided into six groups, such as control group, DQS group, 0.66% NAC group, 3% NAC group, 10% NAC group and dry eye control group. On Day 0, all rats underwent extraorbital and infraorbital lacrimal gland excision surgery on their right eye. Then, on Day 2, all rats underwent corneal epithelial wound induction surgery on both eyes except dry eye control group. The rats in dry eye control group did not induce corneal epithelial wound nor received any eye drops. After corneal wound surgery, topical antibiotics eye drops and designated drugs were administrated four times daily. And, corneal wound evaluation was performed at post-surgery 0, 8, 24, 32, 48 and 72 h. All rats were sacrificed at 72 h post-surgery. The corneal tissue was completely removed and analyzed for the MMP-9 expression level by real-time PCR. Statistical analysis of tear secretion, corneal wound healing rate and corneal MMP-9 expression level was performed. Results: Tear secretion of right eye significantly decreased from one day post-excision of lacrimal gland till the end of the study. And, the corneal fluorescein stain score of right eyes also significantly increased on day 2 in all rats, which meant that dry eye symptoms were shown in all right eyes before corneal epithelial wound induction surgery. The corneal epithelial wound healing rate was significantly slower in right eye compared to left eye in every groups. And, there was no obvious difference in corneal wound size before 48 h post-surgery in right eye of each group. At 72 h, the area of corneal wound of right eye was significantly larger in 0.66% NAC and 10% NAC group than in control group. On the other hand, the area of corneal wound of left eye was significantly larger in 0.66% NAC and 10% NAC than in control and DQS group at 24 h. At 32 h, the corneal wound size of left eye was significantly bigger in 0.66% NAC, 3% NAC and 10% NAC than in control group. Lastly, the corneal MMP-9 expression level was significantly higher in right eye than in left eye in all six groups. Moreover, the MMP-9 expression level of right eye was significantly lower in DQS group, 0.66% NAC, 3% NAC and 10% NAC group than in control group. Among these, MMP-9 expression level in 10% NAC was the lowest. Compared the right eye of control group with dry eye control group, the MMP-9 expression level was significantly higher in the control group. Conclusions: Diquafosol and three different concentrations of N-acetylcysteine could not improve corneal epithelial wound healing in both normal condition and dry eye condition. Diquafosol as well as N-acetylcysteine were therapeutic options of dry eye disease. However, it should take into account that these two drugs may retard corneal epithelial wound healing in dry eye patients. Lastly, suppression of corneal MMP-9 expression was not the right approach to improve corneal epithelial wound healing in dry eye patient. | en |
| dc.description.provenance | Made available in DSpace on 2022-11-25T08:05:38Z (GMT). No. of bitstreams: 1 U0001-2610202116531000.pdf: 37371817 bytes, checksum: 1699bab120a3d7e1866354ec808e4ef5 (MD5) Previous issue date: 2021 | en |
| dc.description.tableofcontents | 謝辭 i
中文摘要 ii Abstract v Chapter I: Introduction 1 1.1 Background 1 1.2 Hypotheses 3 Chapter II: Literature review 4 2.1 Dry eye rat model 4 2.2 Corneal epithelial wound model 5 2.3 Mechanism of corneal epithelial wound healing and the role of matrix metalloproteinase-9 (MMP-9) 6 2.4 Diquafosol (DQS) and its effect on dry eye disease and wound healing 8 2.5 N-acetylcysteine (NAC) and its effect on dry eye disease and wound healing 10 Chapter III: Materials and Methods 12 3.1 Animals 12 3.2 Diquafosol and N-acetylcysteine (NAC) eye drops preparation 12 3.3 Dry eye rat model 12 3.4 Corneal epithelial wound healing model 13 3.5 Study design 14 3.6 Tear volume measurement 15 3.7 Fluorescein stain score 15 3.8 Corneal epithelial wound evaluation 15 3.9 Real-time PCR 16 3.10 Statistical analysis 18 Chapter IV: Results 19 4.1 Tear volume 19 4.2 Fluorescein stain score 20 4.3 Corneal epithelial wound 20 4.4 MMP-9 expression in cornea 22 Chapter V: Discussion 23 5.1 Dry eye model 23 5.2 Corneal wound rat model 24 5.3 Drugs effect on tear secretion 24 5.4 The effect of dry eye on wound healing 25 5.5 Drugs effect on wound healing w/ and w/o dry eye condition 26 5.6 The relation between MMP-9 and wound healing 28 5.7 Limitation 30 Chapter VI: Conclusion 31 References 32 Tables 37 Figures 40 | - |
| dc.language.iso | en | - |
| dc.subject | 癒合速度 | zh_TW |
| dc.subject | 滴舒適®點眼液 | zh_TW |
| dc.subject | 乾眼症 | zh_TW |
| dc.subject | 乙醯半胱氨酸 | zh_TW |
| dc.subject | 角膜上皮傷口 | zh_TW |
| dc.subject | 基 質金屬蛋白酵素 9 | zh_TW |
| dc.subject | wound healing | en |
| dc.subject | diquafosol | en |
| dc.subject | N-acetylcysteine | en |
| dc.subject | MMP-9 | en |
| dc.subject | corneal epithelial wound | en |
| dc.subject | dry eye | en |
| dc.title | 乙醯半胱氨酸和滴舒適點眼液在大鼠乾眼症模型上對角膜上皮傷口癒合的影響 | zh_TW |
| dc.title | The effects of N-acetylcysteine and diquafosol on corneal epithelial wound healing in a dry eye rat model | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 109-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.coadvisor | 胡芳蓉;孫逸珍 | zh_TW |
| dc.contributor.coadvisor | Fung-Rong Hu;Yi-Chen Sun | en |
| dc.contributor.oralexamcommittee | 洪凱風;林荀龍 | zh_TW |
| dc.contributor.oralexamcommittee | Kai-Feng Hung;Shiun-Long Lin | en |
| dc.subject.keyword | 乾眼症; 角膜上皮傷口; 癒合速度; 滴舒適®點眼液; 乙醯半胱氨酸; 基 質金屬蛋白酵素 9 | zh_TW |
| dc.subject.keyword | dry eye; corneal epithelial wound; wound healing; diquafosol; N-acetylcysteine; MMP-9 | en |
| dc.relation.page | 65 | - |
| dc.identifier.doi | 10.6342/NTU202104250 | - |
| dc.rights.note | 未授權 | - |
| dc.date.accepted | 2021-10-27 | - |
| dc.contributor.author-college | 生物資源暨農學院 | - |
| dc.contributor.author-dept | 臨床動物醫學研究所 | - |
| dc.date.embargo-lift | 2026-10-01 | - |
| 顯示於系所單位: | 臨床動物醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-109-2.pdf 未授權公開取用 | 36.5 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
